Press Release: Cambrooke announces the new and improved Glytactin™ Complete Bar

AYER, Mass.–(BUSINESS WIRE)–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, is pleased to announce a new and improved Glytactin Complete Bar, a Medical Food for the dietary management of Phenylketonuria (PKU). The new and improved Glytactin Complete Bar contains glytactin with glycomacropeptide (GMP) with all the…